
Semaglutide · Tirzepatide · Medically Supervised
Historic Downtown Loveland, OH
About This Treatment
At The Skin Cliniq, weight management is approached the same way as every other treatment: clinically, individually, and without shortcuts. Sally offers medically supervised programs using GLP-1 receptor agonist medications — semaglutide and tirzepatide — for clients who qualify. These are FDA-approved medications that work by modulating appetite signaling and supporting metabolic regulation. As a Nurse Practitioner with 25+ years of clinical experience, Sally provides thorough intake evaluation, personalized dosing, and ongoing monitoring — ensuring your program is both safe and appropriately tailored to your health history and goals.
Key Benefits
The Process
01
Your program begins with a thorough clinical intake — reviewing your health history, current medications, metabolic labs, and goals. Sally confirms your candidacy for GLP-1 therapy and discusses which medication is most appropriate for your individual situation.
02
You'll be started on a low dose with a gradual titration schedule designed for tolerability. Sally provides full education on self-administration, what to expect during the titration phase, and how to manage any early side effects.
03
Regular follow-up appointments track your progress, assess tolerability, and adjust dosing as needed. Lab work is reviewed periodically to monitor your metabolic health throughout the program.
04
Weight management is most effective when supported by broader lifestyle guidance. Sally provides nutritional and activity recommendations tailored to complement your medication program and support sustainable long-term results.
Included Treatments
Ready to Begin?
Every treatment begins with a consultation. Sally will assess your skin, discuss your goals, and curate a plan built entirely around you.
Book NowQuestions & Answers
Semaglutide is a GLP-1 receptor agonist — a class of medication that works by activating receptors involved in appetite regulation and glucose metabolism. Tirzepatide is a dual GLP-1/GIP receptor agonist that activates two complementary pathways. Both are FDA-approved for chronic weight management in adults who meet clinical criteria, and both are administered as weekly subcutaneous injections.
Candidacy is determined during your medical intake screening. Generally, GLP-1 medications are appropriate for adults with a BMI of 30 or above, or 27 or above with a weight-related health condition, who have not achieved sufficient results through diet and exercise alone. Certain medical histories and medications may be contraindications. Sally will review your history thoroughly before prescribing.
Clinical outcomes vary significantly based on individual factors including starting weight, adherence, lifestyle, and metabolic health. Sally will give you an honest, clinical assessment of what is realistic for you specifically during your intake appointment — not a marketing number.
The most common side effects are gastrointestinal — nausea, reduced appetite, and occasional GI upset — particularly during the early titration phase. Starting at a low dose and titrating gradually significantly reduces these effects. Sally reviews all potential side effects and contraindications with you during your intake, and monitors for any concerns throughout your program.
Many clients find that weight management and aesthetics goals complement each other. Skin quality, body composition, and overall wellness are deeply interconnected. Sally can coordinate your weight management program with your skincare and injectable treatments as part of a comprehensive approach to looking and feeling your best.
Begin Your Journey
Book a consultation with Sally and receive a personalized treatment plan designed exclusively for your skin.